Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × OTHER_GOV × Olanzapine × Clear all

Phase

Phase NA 1 Phase 3 1

Status

Sponsor Class

OTHER 19 OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Conditions

Interventions

Radiotherapy 9 Carboplatin 7 Cisplatin 6 Capecitabine 6 Neoadjuvant Therapy 5 Gemcitabine 5 Fluorouracil 5 Docetaxel 5 Paclitaxel 4 Cyclophosphamide 4 Trastuzumab 3 Tamoxifen 3 Oxaliplatin 3 Hydralazine 3 Etoposide 3 Drug Therapy 3 pertuzumab 2 pegylated granulocyte colony-stimulating factor 2 palbociclib 2 Valproic Acid 2 Tranexamic Acid 2 Temozolomide 2 TP protocol 2 Surgical Procedures, Operative 2 Saline Solution 2 Radiotherapy, Adjuvant 2 Radiation 2 Proton Pump Inhibitors 2 Pemetrexed 2 Nivolumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04232423 2022-01-21

OLN-EME

Department of Medical Services Ministry of Public Health of Thailand

Phase 3 Completed

Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon ⚡